Nimblegen Pulls IPO

Nimblegen Systems Inc., a Madison, Wis.-based maker of microarrays for the life sciences market, has withdrawn registration for a $75 million IPO. The move follows Nimblegen's acquisition by Roche for $272.5 million. Nimblegen shareholders had included Skyline Ventures (14.04%), Cargill Ventures (13.37%), Schott AG (12.71%), Brookside Capital Partners (7.77%), Venture Investors LLC (6.55%), the State of Wisconsin Investment Board and Baird Venture Partners. www.nimblegen.com